About Edilytics

Edilytics is a bootstrapped (no external funding or investors) software company, built by scientists, for scientists. We build computational tools that bridge the gap between complex genome editing technologies and clear interpretation of next-generation sequencing (NGS) results. Our flagship product, CRISPResso, answers the most important question in genome editing:

“What actually happened in my genome editing experiment?”

We enable genome-editing researchers in both academia and industry to develop therapies, improve crops, and advance biological science. Their success depends on trustworthy, precise analysis—and so does ours. Edilytics is committed to supporting the genome editing community with accurate software tools that enables discovery.